Skip to main content
Clinical Trials/NCT04540848
NCT04540848WithdrawnPhase 4

Post Operative Pain Control for Distal Radius Surgery: Does Exparel Injected at the Surgery Site Improve Postoperative Pain Scores at 24 and 48 Hours ?

The University of Texas Health Science Center, Houston0 sitesStarted: March 1, 2021Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 4
Status
Withdrawn
Primary Endpoint
Pain as measured by the Revised American Pain Society Patient Outcome Questionnaire (APS-POQ-R)

Study Overview

Brief Summary

The purpose of this study is to see if Exparel, used intraoperatively by injecting at the surgical site, followed by a Supraclavicular nerve block with bupivacaine in the recovery room, will provide better pain scores for patients at 24 and 48 hours post operatively than, 1)Bupivacaine Hydrochloride (HCL) injection at the surgical site, with a supraclavicular block in Post-anesthesia care unit(PACU), or 2)a supraclavicular block in PACU without any kind of injection at the surgical site.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Investigator)

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • distal radius fractures
  • undergoing Open reduction internal fixation (ORIF) at Lyndon B Johnson Ambulatory Surgical Center (LBJ ASC)

Exclusion Criteria

  • pregnancy
  • history of chronic pain conditions
  • currently taking opioids

Arms & Interventions

Exparel plus supraclavicular block

Experimental

Intervention: Group A (Exparel plus supraclavicular block) (Drug)

Bupivacaine HCL plus supraclavicular block

Active Comparator

Intervention: Group B (Bupivacaine HCL plus supraclavicular block) (Drug)

supraclavicular block only

Active Comparator

Intervention: Group C(supraclavicular block only) (Drug)

Outcomes

Primary Outcomes

Pain as measured by the Revised American Pain Society Patient Outcome Questionnaire (APS-POQ-R)

Time Frame: 48 hours post treatment

The questionnaire consists of 13 questions.The first 11 is scored form 0-10(a higher number indicating a worse outcome).

Secondary Outcomes

  • Number of prescription opioid medications consumed by the patient(48 hours post surgery)
  • Number of patients who presented to Emergency room following surgery for pain control(48 hours post surgery)
  • Number of over the counter(OTC) pain medications consumed by the patient(24 hours post surgery)
  • Number of OTC pain medications consumed by the patient(48 hours post surgery)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Erikka L Washington

Assistant Professor

The University of Texas Health Science Center, Houston

Similar Trials